No abstract available.

No abstract available.
Toes*

No abstract available.
Toes*

No abstract available.
Darier Disease*

No abstract available.
Myxoma*

No abstract available.
Humans ; Mucocutaneous Lymph Node Syndrome* ; Onycholysis*

Deep learning has recently achieved remarkable results in the field of medical imaging. However, as a deep learning network becomes deeper to improve its performance, it becomes more difficult to interpret the processes within. This can especially be a critical problem in medical fields where diagnostic decisions are directly related to a patient's survival. In order to solve this, explainable artificial intelligence techniques are being widely studied, and an attention mechanism was developed as part of this approach. In this paper, attention techniques are divided into two types: post hoc attention, which aims to analyze a network that has already been trained, and trainable attention, which further improves network performance. Detailed comparisons of each method, examples of applications in medical imaging, and future perspectives will be covered.

Deep learning has recently achieved remarkable results in the field of medical imaging. However, as a deep learning network becomes deeper to improve its performance, it becomes more difficult to interpret the processes within. This can especially be a critical problem in medical fields where diagnostic decisions are directly related to a patient's survival. In order to solve this, explainable artificial intelligence techniques are being widely studied, and an attention mechanism was developed as part of this approach. In this paper, attention techniques are divided into two types: post hoc attention, which aims to analyze a network that has already been trained, and trainable attention, which further improves network performance. Detailed comparisons of each method, examples of applications in medical imaging, and future perspectives will be covered.

BACKGROUND/OBJECTIVES: By the year 2050, thirty-eight percent of the Korean population will be over the age of 65. Health care costs for Koreans over age 65 reached 15.4 trillion Korean won in 2011, accounting for a third of the total health care costs for the population. Chronic degenerative diseases, including coronary heart disease (CHD), drive long-term health care costs at an alarming annual rate. In the elderly population, loss of independence is one of the main reasons for this increase in health care costs. Korean heath policies place a high priority on the prevention of CHD because it is a major cause of morbidity and mortality. SUBJECTS/METHODS: This evidence-based study aims to the estimate potential health care cost savings resulting from the daily intake of omega-3 fatty acid supplementation. Potential cost savings associated with a reduced risk of CHD and the medical costs potentially avoided through risk reduction, including hospitalizations and physician services, were estimated using a Congressional Budget Office cost accounting methodology. RESULTS: The estimate of the seven-year (2005-2011) net savings in medical costs resulting from a reduction in the incidence of CHD among the elderly population through the daily use of omega-3 fatty acids was approximately 210 billion Korean won. Approximately 92,997 hospitalizations due to CHD could be avoided over the seven years. CONCLUSIONS: Our findings suggest that omega-3 supplementation in older individuals may yield substantial cost-savings by reducing the risk of CHD. It should be noted that additional health and cost benefits need to be revisited and re-evaluated as more is known about possible data sources or as new data become available.
Aged* ; Budgets ; Coronary Disease ; Cost Savings ; Cost-Benefit Analysis ; Surveys and Questionnaires ; Fatty Acids, Omega-3 ; Functional Food ; Health Care Costs* ; Hospitalization ; Humans ; Incidence ; Income* ; Korea ; Mortality ; Risk Reduction Behavior

PURPOSE: The Trastuzumab for gastric cancer (GC) trial identified human epidermal growth factor receptor 2 (HER2) as a predictor of successful treatment with trastuzumab (HER2 receptor targeting agent) among patients with advanced/metastatic GC. To date, the prevalence of HER2 overexpression in the Korean population is unknown. The present study aimed to assess the incidence of HER2 positivity among GC and gastroesophageal (GE) junction cancer samples and the relationship between HER2 overexpression and clinicopathological characteristics in Korean patients. MATERIALS AND METHODS: Tumor samples collected from 1,695 patients with histologically proven GC or GE junction enrolled at 14 different hospitals in Korea were examined. After gathering clinicopathological data of all patients, HER2 status was assessed by immunohistochemistry (IHC) at each hospital, and IHC 2+ cases were subjected to silver-enhanced in situ hybridization at 3 central laboratories. RESULTS: A total of 182 specimens tested positive for HER2, whereas 1,505 tested negative. Therefore, the overall HER2-positive rate in this study was 10.8% (95% confidence interval: 9.3%–12.3%). The HER2-positive rate was higher among intestinal-type cases (17.6%) than among other types, and was higher among patients older than 70 years and 50 years of age, compared to other age groups. CONCLUSIONS: Our evaluation of the HER2 positivity rate (10.8%) among Korean patients with GC and GE junction indicated the necessity of epidemiological data when conducting studies related to HER2 expression in GC and GE junction.
Epidemiologic Studies* ; Epidermal Growth Factor* ; Humans* ; Immunohistochemistry ; In Situ Hybridization ; Incidence ; Korea ; Prevalence ; Receptor, Epidermal Growth Factor* ; Receptor, ErbB-2 ; Stomach Neoplasms* ; Trastuzumab